Search research articles
Contact Us
Filters
Showing results (291-300 of 446) with videos related to
Page
of 45
Sort By:
American Journal of Hematology
|
January 2, 2023
Thrombosis in multiple myeloma: Risk estimation by induction regimen and association with overall survival
Charalampos Charalampous, Utkarsh Goel, Prashant Kapoor, et al.
Blood
|
August 16, 2017
Delineation of the timing of second-line therapy post-autologous stem cell transplant in patients with AL amyloidosis
Yi L Hwa, Rahma Warsame, Morie A Gertz, et al.
Mayo Clinic Proceedings
|
March 14, 2007
Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement
Angela Dispenzieri, S Vincent Rajkumar, Morie A Gertz, et al.
Bone Marrow Transplantation
|
July 6, 2020
Prognostic value of NT-ProBNP and troponin T in patients with light chain amyloidosis and kidney dysfunction undergoing autologous stem cell transplantation
Abdullah S Al Saleh, Harsh V Parmar, Iuliana Vaxman, et al.
Mayo Clinic Proceedings
|
May 10, 2017
Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: The Mayo Clinic Experience
Taxiarchis V Kourelis, Robert A Kyle, David Dingli, et al.
American Journal of Hematology
|
June 25, 2016
Induction therapy pre-autologous stem cell transplantation in immunoglobulin light chain amyloidosis: a retrospective evaluation
Yi L Hwa, Shaji K Kumar, Morie A Gertz, et al.
American Journal of Hematology
|
March 15, 2016
Long-term outcome of patients with POEMS syndrome: An update of the Mayo Clinic experience
Taxiarchis V Kourelis, Francis K Buadi, Shaji K Kumar, et al.
American Journal of Hematology
|
August 11, 2016
N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma
Paolo Milani, S Vincent Rajkumar, Giampaolo Merlini, et al.
Leukemia
|
December 17, 2015
Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment
T V Kourelis, F K Buadi, M A Gertz, et al.
Blood Advances
|
January 25, 2020
Utility of serum free light chain ratio in response definition in patients with multiple myeloma
Nadine Abdallah, Prashant Kapoor, David L Murray, et al.
Page
of 45
Search research articles
Search
Showing results (291-300 of 446) with videos related to
Sort By:
Page
of 45
American Journal of Hematology
|
January 2, 2023
Thrombosis in multiple myeloma: Risk estimation by induction regimen and association with overall survival
Charalampos Charalampous, Utkarsh Goel, Prashant Kapoor, et al.
Blood
|
August 16, 2017
Delineation of the timing of second-line therapy post-autologous stem cell transplant in patients with AL amyloidosis
Yi L Hwa, Rahma Warsame, Morie A Gertz, et al.
Mayo Clinic Proceedings
|
March 14, 2007
Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement
Angela Dispenzieri, S Vincent Rajkumar, Morie A Gertz, et al.
Bone Marrow Transplantation
|
July 6, 2020
Prognostic value of NT-ProBNP and troponin T in patients with light chain amyloidosis and kidney dysfunction undergoing autologous stem cell transplantation
Abdullah S Al Saleh, Harsh V Parmar, Iuliana Vaxman, et al.
Mayo Clinic Proceedings
|
May 10, 2017
Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: The Mayo Clinic Experience
Taxiarchis V Kourelis, Robert A Kyle, David Dingli, et al.
American Journal of Hematology
|
June 25, 2016
Induction therapy pre-autologous stem cell transplantation in immunoglobulin light chain amyloidosis: a retrospective evaluation
Yi L Hwa, Shaji K Kumar, Morie A Gertz, et al.
American Journal of Hematology
|
March 15, 2016
Long-term outcome of patients with POEMS syndrome: An update of the Mayo Clinic experience
Taxiarchis V Kourelis, Francis K Buadi, Shaji K Kumar, et al.
American Journal of Hematology
|
August 11, 2016
N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma
Paolo Milani, S Vincent Rajkumar, Giampaolo Merlini, et al.
Leukemia
|
December 17, 2015
Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment
T V Kourelis, F K Buadi, M A Gertz, et al.
Blood Advances
|
January 25, 2020
Utility of serum free light chain ratio in response definition in patients with multiple myeloma
Nadine Abdallah, Prashant Kapoor, David L Murray, et al.
Page
of 45